atai Life Sciences (ATAI) Misses Q2 EPS by 1c

atai Life Sciences (NASDAQ: ATAI) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $170 thousand, versus $0 reported last year.

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• BofA cuts PG&E to Neutral as California wildfire reforms fall short
• Everus Construction Group acquires Epsilon Industries for $295M